5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease

Omidreza Firuzi, Jiamin Zhuo, Cinzia M. Chinnici, Thomas Wisniewski, Domenico Praticò

Research output: Contribution to journalArticle

117 Citations (Scopus)

Abstract

5-Lipoxygenase (5LO), by producing leukotrienes, is a proinflammatory enzyme, and there is evidence suggesting that it is up-regulated with aging and may be involved in Alzheimer's disease (AD). In this paper, we studied the effect of 5LO-targeted gene disruption on the amyloid phenotype of a transgenic mouse model of AD, the Tg2576. Amyloid-β (Aβ) deposition in the brains of Tg2576 mice lacking 5LO was reduced by 64-80% compared with Tg2576 controls. This reduction was associated with a similar significant decrease in Aβ levels measured by sandwich ELISA. Absence of 5LO did not induce any significant change in amyloid-β precursor protein (APP) levels and processing, or Aβ catabolic pathways. Furthermore, in vitro studies showed that 5LO activation or 5LO metabolites increase, whereas 5LO inhibition decreases, Aβ formation, secondary to correspondent changes in γ-secretase activity. These data establish for the first time a novel functional role for 5LO in the pathogenesis of AD-like amyloidosis, thereby modulating γ-secretase activity. Our work suggests that pharmacological inhibition of 5LO could provide a novel therapeutic tool for AD.

Original languageEnglish
Pages (from-to)1169-1178
Number of pages10
JournalFASEB Journal
Volume22
Issue number4
DOIs
Publication statusPublished - Apr 2008

Fingerprint

Arachidonate 5-Lipoxygenase
gene targeting
Pathology
amyloid
Alzheimer disease
lipoxygenase
Amyloid
Alzheimer Disease
Genes
animal models
Amyloid Precursor Protein Secretases
amyloidosis
leukotrienes
Leukotrienes
Amyloid beta-Protein Precursor
sandwiches
Amyloidosis
Metabolites
in vitro studies
Transgenic Mice

Keywords

  • γ-secretase
  • Amyloid-β precursor protein
  • Leukotrienes
  • Tg2576

ASJC Scopus subject areas

  • Agricultural and Biological Sciences (miscellaneous)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology

Cite this

5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease. / Firuzi, Omidreza; Zhuo, Jiamin; Chinnici, Cinzia M.; Wisniewski, Thomas; Praticò, Domenico.

In: FASEB Journal, Vol. 22, No. 4, 04.2008, p. 1169-1178.

Research output: Contribution to journalArticle

Firuzi, Omidreza ; Zhuo, Jiamin ; Chinnici, Cinzia M. ; Wisniewski, Thomas ; Praticò, Domenico. / 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease. In: FASEB Journal. 2008 ; Vol. 22, No. 4. pp. 1169-1178.
@article{4507b554a9654582bb9936f2eb112b6d,
title = "5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease",
abstract = "5-Lipoxygenase (5LO), by producing leukotrienes, is a proinflammatory enzyme, and there is evidence suggesting that it is up-regulated with aging and may be involved in Alzheimer's disease (AD). In this paper, we studied the effect of 5LO-targeted gene disruption on the amyloid phenotype of a transgenic mouse model of AD, the Tg2576. Amyloid-β (Aβ) deposition in the brains of Tg2576 mice lacking 5LO was reduced by 64-80{\%} compared with Tg2576 controls. This reduction was associated with a similar significant decrease in Aβ levels measured by sandwich ELISA. Absence of 5LO did not induce any significant change in amyloid-β precursor protein (APP) levels and processing, or Aβ catabolic pathways. Furthermore, in vitro studies showed that 5LO activation or 5LO metabolites increase, whereas 5LO inhibition decreases, Aβ formation, secondary to correspondent changes in γ-secretase activity. These data establish for the first time a novel functional role for 5LO in the pathogenesis of AD-like amyloidosis, thereby modulating γ-secretase activity. Our work suggests that pharmacological inhibition of 5LO could provide a novel therapeutic tool for AD.",
keywords = "γ-secretase, Aβ, Amyloid-β precursor protein, Leukotrienes, Tg2576",
author = "Omidreza Firuzi and Jiamin Zhuo and Chinnici, {Cinzia M.} and Thomas Wisniewski and Domenico Pratic{\`o}",
year = "2008",
month = "4",
doi = "10.1096/fj.07-9131.com",
language = "English",
volume = "22",
pages = "1169--1178",
journal = "FASEB Journal",
issn = "0892-6638",
publisher = "FASEB",
number = "4",

}

TY - JOUR

T1 - 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease

AU - Firuzi, Omidreza

AU - Zhuo, Jiamin

AU - Chinnici, Cinzia M.

AU - Wisniewski, Thomas

AU - Praticò, Domenico

PY - 2008/4

Y1 - 2008/4

N2 - 5-Lipoxygenase (5LO), by producing leukotrienes, is a proinflammatory enzyme, and there is evidence suggesting that it is up-regulated with aging and may be involved in Alzheimer's disease (AD). In this paper, we studied the effect of 5LO-targeted gene disruption on the amyloid phenotype of a transgenic mouse model of AD, the Tg2576. Amyloid-β (Aβ) deposition in the brains of Tg2576 mice lacking 5LO was reduced by 64-80% compared with Tg2576 controls. This reduction was associated with a similar significant decrease in Aβ levels measured by sandwich ELISA. Absence of 5LO did not induce any significant change in amyloid-β precursor protein (APP) levels and processing, or Aβ catabolic pathways. Furthermore, in vitro studies showed that 5LO activation or 5LO metabolites increase, whereas 5LO inhibition decreases, Aβ formation, secondary to correspondent changes in γ-secretase activity. These data establish for the first time a novel functional role for 5LO in the pathogenesis of AD-like amyloidosis, thereby modulating γ-secretase activity. Our work suggests that pharmacological inhibition of 5LO could provide a novel therapeutic tool for AD.

AB - 5-Lipoxygenase (5LO), by producing leukotrienes, is a proinflammatory enzyme, and there is evidence suggesting that it is up-regulated with aging and may be involved in Alzheimer's disease (AD). In this paper, we studied the effect of 5LO-targeted gene disruption on the amyloid phenotype of a transgenic mouse model of AD, the Tg2576. Amyloid-β (Aβ) deposition in the brains of Tg2576 mice lacking 5LO was reduced by 64-80% compared with Tg2576 controls. This reduction was associated with a similar significant decrease in Aβ levels measured by sandwich ELISA. Absence of 5LO did not induce any significant change in amyloid-β precursor protein (APP) levels and processing, or Aβ catabolic pathways. Furthermore, in vitro studies showed that 5LO activation or 5LO metabolites increase, whereas 5LO inhibition decreases, Aβ formation, secondary to correspondent changes in γ-secretase activity. These data establish for the first time a novel functional role for 5LO in the pathogenesis of AD-like amyloidosis, thereby modulating γ-secretase activity. Our work suggests that pharmacological inhibition of 5LO could provide a novel therapeutic tool for AD.

KW - γ-secretase

KW - Aβ

KW - Amyloid-β precursor protein

KW - Leukotrienes

KW - Tg2576

UR - http://www.scopus.com/inward/record.url?scp=42049114647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049114647&partnerID=8YFLogxK

U2 - 10.1096/fj.07-9131.com

DO - 10.1096/fj.07-9131.com

M3 - Article

C2 - 17998412

AN - SCOPUS:42049114647

VL - 22

SP - 1169

EP - 1178

JO - FASEB Journal

JF - FASEB Journal

SN - 0892-6638

IS - 4

ER -